BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29955617)

  • 1. Risk Factors for Viridans Group Streptococcal Bacteremia in Neutropenic and Non-neutropenic Patients: A Single Center Case-Case-Control Study.
    Dulanto Chiang A; Sinaii N; Palmore TN
    Open Forum Infect Dis; 2018 Jan; 5(1):ofx260. PubMed ID: 29955617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
    Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
    Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility.
    Shargian L; Paul M; Nachshon T; Ayada G; Nesher L; Raanani P; Ben-Zvi H; Henig O; Yahav D
    Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):177-182. PubMed ID: 36502498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
    Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
    Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
    Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
    Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia.
    Wo S; Dubrovskaya Y; Siegfried J; Papadopoulos J; Jen SP
    Open Forum Infect Dis; 2021 Jan; 8(1):ofaa542. PubMed ID: 33511221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Corticosteroids in Adult Respiratory Distress Syndrome caused by Viridans Group Streptococci Bacteremia in Neutropenic Patients.
    Yacoub AT; Mojica L; Jones L; Knab A; Alrabaa S; Greene J
    Mediterr J Hematol Infect Dis; 2014; 6(1):e2014055. PubMed ID: 25237468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting bacteremia caused by Streptococcus anginosus group: A new scoring method.
    Isa K; Matsuo T; Onishi K; Mori N
    J Infect Chemother; 2022 Dec; 28(12):1628-1631. PubMed ID: 36049615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
    J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.
    Bochud PY; Eggiman P; Calandra T; Van Melle G; Saghafi L; Francioli P
    Clin Infect Dis; 1994 Jan; 18(1):25-31. PubMed ID: 8054434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
    Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics and microbiological profile of viridans group streptococci bacteremia in children with cancer and high-risk febrile neutropenia].
    Cortés D; Maldonado ME; Rivacoba MC; Maza V; Valenzuela R; Payá E; Contardo V; Álvarez AM; Avilés CL; Becker A; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Viviani T; Zubieta M; Santolaya ME
    Rev Chilena Infectol; 2020 Aug; 37(4):383-388. PubMed ID: 33399658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptococcus mitis strains causing severe clinical disease in cancer patients.
    Shelburne SA; Sahasrabhojane P; Saldana M; Yao H; Su X; Horstmann N; Thompson E; Flores AR
    Emerg Infect Dis; 2014 May; 20(5):762-71. PubMed ID: 24750901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.
    Wisplinghoff H; Reinert RR; Cornely O; Seifert H
    J Clin Microbiol; 1999 Jun; 37(6):1876-80. PubMed ID: 10325340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete Genome Sequence of Streptococcus mitis Strain SVGS_061 Isolated from a Neutropenic Patient with Viridans Group Streptococcal Shock Syndrome.
    Petrosyan V; Holder M; Ajami NJ; Petrosino JF; Sahasrabhojane P; Thompson EJ; Kalia A; Shelburne SA
    Genome Announc; 2016 Apr; 4(2):. PubMed ID: 27056234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viridans streptococcal bacteraemia in patients with neutropenia.
    Richard P; Amador Del Valle G; Moreau P; Milpied N; Felice MP; Daeschler T; Harousseau JL; Richet H
    Lancet; 1995 Jun; 345(8965):1607-9. PubMed ID: 7783538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental health and viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
    Graber CJ; de Almeida KN; Atkinson JC; Javaheri D; Fukuda CD; Gill VJ; Barrett AJ; Bennett JE
    Bone Marrow Transplant; 2001 Mar; 27(5):537-42. PubMed ID: 11313689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteremia due to viridans streptococci in neutropenic patients: a review.
    Bochud PY; Calandra T; Francioli P
    Am J Med; 1994 Sep; 97(3):256-64. PubMed ID: 8092175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
    Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
    Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.